Prevalence of Glu323Lys Mutation of the TIGR/MYOC Gene and Risk Factors amongst Primary Open-angle Glaucoma Patients in Ouagadougou, Burkina Faso
Lassina Traoré, Jérôme Sanou, Bélélé S Bakyono, Abdou A Zoure, Théodora M Zohoncon, Hermann K Sombié, Albert T Yonli, Guertrude Meda-Hien, Ezechiel B Tibiri, Florencia W Djigma, Jacques Simpore
Aim: Glaucoma is a group of degenerative diseases of the optic nerve whose predisposing factors may be genetic. The objective of this study was to estimate the frequency of the Glu323Lys mutation as a genetic risk factor for glaucoma.
Materials and methods: A cross-sectional study over 6 months from October 2020 to March 2021 in Ouagadougou, Burkina Faso. A total of 89 samples of patients with primary open-angle glaucoma (POAG) were collected. The frequency of the Glu323Lys mutation of the myocilin, trabecular meshwork inducible glucocorticoid response (TIGR/MYOC) gene by polymerase chain reaction (PCR)—restriction fragment length polymorphism.
Results: In glaucoma patients, only homozygous nonmutated guanine-guanine (GG) and heterozygous mutated adenine-guanine (AG) genotypes were found in 96.63 and 3.37% of cases, respectively. Around 69.66% of patients had a family history of glaucoma, 28.09% had a history of hypertension, and 7.86% had a history of diabetes.
Conclusion: The frequency of the Glu323Lys mutation of the TIGR/MYOC gene was 3.37% in the glaucoma population in Ouagadougou. A case-control study is necessary to know the contribution of the Glu323Lys mutation as a genetic risk factor for glaucoma in our study population.
Clinical significance: This study constituted the beginning of genetic investigations of glaucoma in our context and showed a low Glu323Lys mutation.
OMS. Maladies oculaires prioritaires. WHO. Published November 3, 2020. Accessed November 3, 2020. https://www.who.int/blindness/causes/priority/fr/index7.html
Thylefors B, Négrel AD. Le glaucome dans le monde. Bull World Health Organ 1994;72(4):539–542.
Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology 2014;121(11):2081–2090. DOI: 10.1016/j.ophtha.2014.05.013
Bron A, Chaine G, Villain M, et al. Les facteurs de risque du glaucome primitif à angle ouvert. J Fr Ophtalmol 2008;31(4):435–444. DOI: 10.1016/S0181-5512(08)71443-8
Racette L, Wilson MR, Zangwill LM, et al. Primary open-angle glaucoma in blacks: a review. Surv Ophthalmol 2003;48(3):295–313. DOI: 10.1016/S0039-6257(03)00028-6
Friedman DS, Wolfs RCW, O'Colmain BJ, et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol 2004;122(4):532–538. DOI: 10.1001/archopht.122.4.532
Quigley HA, West SK, Rodriguez J, et al. The prevalence of glaucoma in a population-based study of hispanic subjects: proyecto VER. Arch Ophthalmol 2001;119(12):1819–1826. DOI: 10.1001/archopht.119.12.1819
Le A, Mukesh BN, McCarty CA, et al. Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci 2003;44(9):3783–3789. DOI: 10.1167/iovs.03-0077
Gordon MO, Beiser JA, Brandt JD, et al. The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120(6):714–720. DOI: 10.1001/archopht.120.6.714
Wang HW, Sun P, Chen Y, et al. Research progress on human genes involved in the pathogenesis of glaucoma (review). Mol Med Rep 2018;18(1):656–674. DOI: 10.3892/mmr.2018.9071
Kumar S, Malik MA, Goswami S, et al. Candidate genes involved in the susceptibility of primary open angle glaucoma. Gene 2016;577(2):119–131. DOI: 10.1016/j.gene.2015.11.032
Faiq M, Sharma R, Dada R, et al. Genetic, biochemical and clinical insights into primary congenital glaucoma. J Curr Glaucoma Pract 2013;7(2):66–84. DOI: 10.5005/jp-journals-10008-1140
Bresson-Dumont H, Zanlonghi X, Bodet S, et al. Le Glaucome: bases moléculaires et diagnostic génétique en France. J Fr Ophtalmol 2005. DOI: 10.1016/S0181-5512(05) 73593-2
Belleau P. Identification des gènes modifiant l’âge d'apparition du glaucome primaire à angle-ouvert dans une famille canadienne-française fondatrice. Thèse de doctorat en medécine moléculaire. Québec; 2016. Accessed August 9, 2019.
Rozsa FW, Shimizu S, Lichter PR, et al. GLC1A mutations point to regions of potential functional importance on the TIGR/MYOC protein. Mol Vis 1998;4:20. PMID: 9772276.
Ahnoux-Zabsonre A, Keita C, Safede K. et al. Prévalence du glaucome chronique primitif à angle ouvert en Côte d'Ivoire. J Fr Ophtalmol 1998;21(9):643–647. PMID: 9894202.
Boodhna T, Saunders LJ, Crabb DP. Are rates of vision loss in patients in English glaucoma clinics slowing down over time? Trends from a decade of data. Eye (Lond) 2015;29(12):1613–1619. DOI: 10.1038/eye.2015.161
Mookherjee S, Acharya M, Banerjee D, et al. Molecular basis for involvement of CYP1B1 in MYOC upregulation and its potential implication in glaucoma pathogenesis. PLoS ONE 2012;7(9):e45077. DOI: 10.1371/journal.pone.0045077
Vittitow JL, Borrás T. Expression of optineurin, a glaucoma-linked gene, is influenced by elevated intraocular pressure. Biochem Biophys Res Commun 2002;298(1):67–74. DOI: 10.1016/S0006-291X(02)02395-1
Eballé AO, Owono D, Bella AL, et al. Caractéristiques cliniques et épidémiologiques du glaucome chronique à angle ouvert. Cah Santé 2008;18(1):19–23. DOI: 10.1684/san.2008.0095
Leske MC, Connell AM, Wu SY, et al. Risk factors for open-angle glaucoma: the barbados eye study. Arch Ophthalmol 1995;113(7):918–924. DOI: 10.1001/archopht.1995.01100070092031
Wu SY, Nemesure B, Hennis A, et al. Nine-year changes in intraocular pressure: the barbados eye studies. Arch Ophthalmol 2006;124(11):1631–1636. DOI: 10.1001/archopht.124.11.1631
Atipo-Tsiba PW. Le glaucome primitif à angle ouvert: Evaluation du niveau de connaissance du médecin généraliste à Brazzaville sur cette maladie. Rwanda Med J 2015;72(3):14–16.
Kooner KS, Joseph A, Shar A, et al. Dallas glaucoma registry: preliminary results. J Clin Exp Ophthalmol 2011;2(6):164. DOI: 10.4172/2155-9570.1000164
Charliat G, Jolly D, Blanchard F. Genetic risk factor in primary open-angle glaucoma: a case-control study. Ophthalmic Epidemiol 1994;1(3):131–138. DOI: 10.3109/09286589409047221
Wilson MR, Hertzmark E, Walker AM, et al. A case-control study of risk factors in open angle glaucoma. Arch Ophthalmol 1987;105(8):1066–1071. DOI: 10.1001/archopht.1987.01060080068030
Wu SY, Leske MC. Associations with intraocular pressure in the barbados eye study. Arch Ophthalmol 1997;115(12):1572–1576. DOI: 10.1001/archopht.1997.01100160742012
Stuart KV, Madjedi K, Luben RN, et al. Alcohol, intraocular pressure, and open-angle glaucoma: a systematic review and meta-analysis. Ophthalmology 2022;129(6):637–652. DOI: 10.1016/j.ophtha.2022.01.023
Li M, Wang M, Guo W, et al. The effect of caffeine on intraocular pressure: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol 2011;249(3):435–442. DOI: 10.1007/s00417-010-1455-1
Charles-Edouard P. Les effets de l'activité physique et sportive sur les maladies cardiovasculaires. 2016.
Dielemans I, de Jong PT, Stolk R, et al. Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. Ophthalmology 1996;103(8):1271–1275. DOI: 10.1016/S0161-6420(96)30511-3
Bonomi L, Marchini G, Marraffa M, et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt study. Ophthalmology 2000;107(7):1287–1293. DOI: 10.1016/S0161-6420(00)00138-X
Jonas JB, Gründler AE. Prevalence of diabetes mellitus and arterial hypertension in primary and secondary open-angle glaucomas. Graefes Arch Clin Exp Ophthalmol 1998;236(3):202–206. DOI: 10.1007/s004170050065
